Block Grant 2235WATRPH

Federal Project Grant Award Summary The National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded Columbia University's Health Sciences Division a $902,272 Project Grant effective May 1, 2026, through April 30, 2028, to advance RF-409, a first-in-class synthetic insulin receptor (IR) agonist designed to treat congenital severe insulin resistance syndromes, including Donohue and Rabson-Mendenhall syndromes. These rare, life-threatening disorders caused by insulin...

Federal Grant Award Summary Rerx Therapeutics, Inc. received a $2.81 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 10, 2025, with completion targeted for June 30, 2027. The project focuses on developing RERX-001, an orally bioavailable small molecule therapeutic designed to address obesity and associated metabolic disorders...

This federal Formula Grant award, provided by the Federal Highway Administration (FHWA) under the Recreational Trails Program (CFDA 20.219), will fund the construction of a approximately 0.46-mile trail with access ramps, as well as resource surveys and engineering work, for the Memorial Park Conservancy in Texas. The total award amount is $375,000.00, with a performance period starting on June 21, 2024. The primary awardee for this grant is the Texas Department of Transportation (TxDOT),...

Summary The University of California, San Diego received a $240,000 Project Grant award dated July 14, 2026, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research investigating the parasite proteasome as a novel antimicrobial target for treating cryptosporidiosis, a severe diarrheal disease caused by Cryptosporidium parvum that poses significant threats to children and...

Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $489,500 Project Grant award from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) effective June 5, 2025, through May 31, 2027. The award funds research and development activities focused on translating the compound REPSOX and its analogs toward clinical application as a prophylactic intervention for Familial Platelet Disorder with Associated Myeloid Malignancy (FPDMM),...

The Department of Transportation Federal Highway Administration awarded $574,220.12 under the Recreational Trails Program (CFDA 20.219) on September 22, 2022 to the California Department of Transportation for the 2021 Recreational Trails Project: Azalea Hill Trail Development. The project will develop approximately 6,400 linear feet of new multi-use trail, construct a new bridge, retaining wall, causeway, armored rock crossings, and a kiosk in the Mt. Tamalpais Watershed. Additionally, the...

This Project Grant award from the National Center for Advancing Translational Sciences (NCATS) under CFDA 93.350 will provide $463,150 to The Regents of the University of California, San Francisco (UCSF) to establish proof-of-concept for enzyme replacement therapy (ERT) as a lifesaving treatment for sphingosine phosphate lyase insufficiency syndrome (SPLIS), an ultra-rare and often lethal metabolic disorder. The project aims to demonstrate the efficacy of ERT in preserving kidney function and...

The Department of Transportation Federal Highway Administration awarded a $230,211.87 Formula Grant under the Recreational Trails Program (CFDA 20.219) to the Colorado Department of Transportation on March 28, 2022. The grant funding will support PROJECT TITLE: RT 2022 SNOW GROOMING 6 OF 6, which involves snow grooming services for recreational trails in Colorado. The Recreational Trails Program provides funds to states to develop and maintain recreational trails and trail-related facilities for...

Federal Grant Award Summary Award: Project Grant | Funding Agency: National Center for Advancing Translational Sciences (NCATS) | Program: NCATS (CFDA 93.350) | Awardee: Simplusdx, Inc. | Amount: $306,299 | Award Date: July 1, 2025 | Performance Period: July 1, 2025 – June 30, 2026 Simplusdx, Inc. will develop and validate a rapid point-of-care testing platform for therapeutic drug monitoring of tacrolimus, a critical immunosuppressive medication used in organ transplantation. The project adapts...

The Department of Transportation Federal Highway Administration awarded $231,043 under the Recreational Trails Program (CFDA 20.219) on February 28, 2023 to the California Department of Transportation. The funding will support the Development EZ OHV Trailheads Phase 1 project to construct three off-highway vehicle staging areas totaling approximately 5.5 acres. Specifically, the award will finance parking and staging areas at the Weasel, Bullseye, and Boca Dam locations, as well as the...